Position in PTGX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,607,268
+$215,778 QoQ
Shares Held
13,112
-0.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 341 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $201,859,483 across 149 Biotechnology names. PTGX ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,898 | $40,681,193 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,244 | $18,234,803 | |
| 3 | TECH |
BIO-TECHNE Corp
|
117,371 | $8,292,261 | |
| 4 | VCEL |
Vericel Corp
|
185,051 | $8,232,918 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
65,659 | $7,529,117 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
95,681 | $7,488,951 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
87,238 | $6,497,486 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
193,236 | $6,452,150 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,607,268 | 13,112 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,391,490 | 13,202 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $28,560 | 327 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $20,394 | 307 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $11,661 | 211 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $13,637 | 282 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $3,551 | 92 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $4,635 | 103 | Shares | Defined | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||